APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom DNA Oligos

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom DNA Oligos Market Outlook and Growth Opportunities 2026

Report ID 173981730423 December 2025203 pages

Choose your research edition.

Industry ResearchCustom DNA Oligos Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom DNA Oligos Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Custom DNA Oligos Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom DNA Oligos Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom DNA Oligos Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Custom DNA Oligos market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom DNA Oligos market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom DNA Oligos market include Wuhan GeneCreate Biological Engineering, General Biol, Atantares, Beyotime, Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio and Tsingke, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom DNA Oligos market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom DNA Oligos and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom DNA Oligos revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom DNA Oligos market.

Custom DNA Oligos Segment by Company

Wuhan GeneCreate Biological Engineering

General Biol

Atantares

Beyotime

Thermo Fisher Scientific

Merck

Genscript

Guangzhou RiboBio

Tsingke

Abace Biotechnology

TriLink BioTechnologies

Synbio Technologies

Macrogen

Integrated DNA Technologies (IDT)

Eurogentec

Cusabio

BBI Life Sciences

Azenta Life Sciences

Aurigene Pharmaceutical Services

Custom DNA Oligos Segment by Type

Common Primer Synthesis

Modified Primer Synthesis

Custom DNA Oligos Segment by Application

Biotech Company

Academic Scientific Research Institution

Custom DNA Oligos Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom DNA Oligos status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom DNA Oligos key companies, revenue, market share, and recent developments.

3. To split the Custom DNA Oligos breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom DNA Oligos market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom DNA Oligos significant trends, drivers, influence factors in global and regions.

6. To analyze Custom DNA Oligos competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom DNA Oligos market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom DNA Oligos and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom DNA Oligos.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom DNA Oligos industry.

Chapter 3: Detailed analysis of Custom DNA Oligos company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom DNA Oligos in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom DNA Oligos in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom DNA Oligos Industry Trends Table 2. Custom DNA Oligos Industry Drivers Table 3. Custom DNA Oligos Industry Opportunities and Challenges Table 4. Custom DNA Oligos Industry Restraints Table 5. Global Custom DNA Oligos Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom DNA Oligos Revenue Share by Company (2021-2026) Table 7. Global Custom DNA Oligos Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom DNA Oligos Key Company Manufacturing Base & Headquarters Table 9. Global Custom DNA Oligos Company, Product Type & Application Table 10. Global Custom DNA Oligos Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom DNA Oligos by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Common Primer Synthesis Table 15. Significant Companies of Modified Primer Synthesis Table 16. Global Custom DNA Oligos Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Custom DNA Oligos Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Custom DNA Oligos Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Custom DNA Oligos Sales Value Share by Type (2021-2026) Table 20. Global Custom DNA Oligos Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biotech Company Table 22. Significant Companies of Academic Scientific Research Institution Table 23. Global Custom DNA Oligos Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Custom DNA Oligos Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Custom DNA Oligos Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Custom DNA Oligos Sales Value Share by Application (2021-2026) Table 27. Global Custom DNA Oligos Sales Value Share by Application (2027-2032) Table 28. Global Custom DNA Oligos Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Custom DNA Oligos Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Custom DNA Oligos Sales Value Share by Region (2021-2026) Table 31. Global Custom DNA Oligos Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Custom DNA Oligos Sales Value Share by Region (2027-2032) Table 33. Global Custom DNA Oligos Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Custom DNA Oligos Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Custom DNA Oligos Sales Value Market Share by Country (2021-2026) Table 36. Global Custom DNA Oligos Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Custom DNA Oligos Sales Value Market Share by Country (2027-2032) Table 38. Wuhan GeneCreate Biological Engineering Company Information Table 39. Wuhan GeneCreate Biological Engineering Business Overview Table 40. Wuhan GeneCreate Biological Engineering Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Wuhan GeneCreate Biological Engineering Custom DNA Oligos Product Portfolio Table 42. Wuhan GeneCreate Biological Engineering Recent Development Table 43. General Biol Company Information Table 44. General Biol Business Overview Table 45. General Biol Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. General Biol Custom DNA Oligos Product Portfolio Table 47. General Biol Recent Development Table 48. Atantares Company Information Table 49. Atantares Business Overview Table 50. Atantares Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Atantares Custom DNA Oligos Product Portfolio Table 52. Atantares Recent Development Table 53. Beyotime Company Information Table 54. Beyotime Business Overview Table 55. Beyotime Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Beyotime Custom DNA Oligos Product Portfolio Table 57. Beyotime Recent Development Table 58. Thermo Fisher Scientific Company Information Table 59. Thermo Fisher Scientific Business Overview Table 60. Thermo Fisher Scientific Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Thermo Fisher Scientific Custom DNA Oligos Product Portfolio Table 62. Thermo Fisher Scientific Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Custom DNA Oligos Product Portfolio Table 67. Merck Recent Development Table 68. Genscript Company Information Table 69. Genscript Business Overview Table 70. Genscript Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Genscript Custom DNA Oligos Product Portfolio Table 72. Genscript Recent Development Table 73. Guangzhou RiboBio Company Information Table 74. Guangzhou RiboBio Business Overview Table 75. Guangzhou RiboBio Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Guangzhou RiboBio Custom DNA Oligos Product Portfolio Table 77. Guangzhou RiboBio Recent Development Table 78. Tsingke Company Information Table 79. Tsingke Business Overview Table 80. Tsingke Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tsingke Custom DNA Oligos Product Portfolio Table 82. Tsingke Recent Development Table 83. Abace Biotechnology Company Information Table 84. Abace Biotechnology Business Overview Table 85. Abace Biotechnology Custom DNA Oligos Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Abace Biotechnology Custom DNA Oligos Product Portfolio Table 87. Abace Biotechnology Recent Development Table 88. TriLink BioTechnologies Company Information Table 89. TriLink BioTechnologies Business Overview Table 90. TriLink BioTechnologies Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. TriLink BioTechnologies Custom DNA Oligos Product Portfolio Table 92. TriLink BioTechnologies Recent Development Table 93. Synbio Technologies Company Information Table 94. Synbio Technologies Business Overview Table 95. Synbio Technologies Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Synbio Technologies Custom DNA Oligos Product Portfolio Table 97. Synbio Technologies Recent Development Table 98. Macrogen Company Information Table 99. Macrogen Business Overview Table 100. Macrogen Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Macrogen Custom DNA Oligos Product Portfolio Table 102. Macrogen Recent Development Table 103. Integrated DNA Technologies (IDT) Company Information Table 104. Integrated DNA Technologies (IDT) Business Overview Table 105. Integrated DNA Technologies (IDT) Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Integrated DNA Technologies (IDT) Custom DNA Oligos Product Portfolio Table 107. Integrated DNA Technologies (IDT) Recent Development Table 108. Eurogentec Company Information Table 109. Eurogentec Business Overview Table 110. Eurogentec Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Eurogentec Custom DNA Oligos Product Portfolio Table 112. Eurogentec Recent Development Table 113. Cusabio Company Information Table 114. Cusabio Business Overview Table 115. Cusabio Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Cusabio Custom DNA Oligos Product Portfolio Table 117. Cusabio Recent Development Table 118. BBI Life Sciences Company Information Table 119. BBI Life Sciences Business Overview Table 120. BBI Life Sciences Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. BBI Life Sciences Custom DNA Oligos Product Portfolio Table 122. BBI Life Sciences Recent Development Table 123. Azenta Life Sciences Company Information Table 124. Azenta Life Sciences Business Overview Table 125. Azenta Life Sciences Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Azenta Life Sciences Custom DNA Oligos Product Portfolio Table 127. Azenta Life Sciences Recent Development Table 128. Aurigene Pharmaceutical Services Company Information Table 129. Aurigene Pharmaceutical Services Business Overview Table 130. Aurigene Pharmaceutical Services Custom DNA Oligos Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Aurigene Pharmaceutical Services Custom DNA Oligos Product Portfolio Table 132. Aurigene Pharmaceutical Services Recent Development Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Custom DNA Oligos Product Image Figure 2. Global Custom DNA Oligos Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom DNA Oligos Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom DNA Oligos Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Common Primer Synthesis Image Figure 8. Modified Primer Synthesis Image Figure 9. Global Custom DNA Oligos Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Custom DNA Oligos Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Custom DNA Oligos Sales Value Share by Type (2021-2032) Figure 12. Biotech Company Image Figure 13. Academic Scientific Research Institution Image Figure 14. Global Custom DNA Oligos Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Custom DNA Oligos Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Custom DNA Oligos Sales Value Share by Application (2021-2032) Figure 17. Global Custom DNA Oligos Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Custom DNA Oligos Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Custom DNA Oligos Sales Value (2021-2032) & (US$ Million) Figure 20. North America Custom DNA Oligos Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Custom DNA Oligos Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Custom DNA Oligos Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Custom DNA Oligos Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Custom DNA Oligos Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Custom DNA Oligos Sales Value (2021-2032) & (US$ Million) Figure 26. South America Custom DNA Oligos Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Custom DNA Oligos Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Custom DNA Oligos Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Custom DNA Oligos Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Common Primer Synthesis
  • Modified Primer Synthesis
Applications
  • Biotech Company
  • Academic Scientific Research Institution
Companies covered
  • Wuhan GeneCreate Biological Engineering
  • General Biol
  • Atantares
  • Beyotime
  • Thermo Fisher Scientific
  • Merck
  • Genscript
  • Guangzhou RiboBio
  • Tsingke
  • Abace Biotechnology
  • TriLink BioTechnologies
  • Synbio Technologies
  • Macrogen
  • Integrated DNA Technologies (IDT)
  • Eurogentec
  • Cusabio
  • BBI Life Sciences
  • Azenta Life Sciences
  • Aurigene Pharmaceutical Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom DNA Oligos Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom DNA Oligos Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom DNA Oligos Market Dynamics
  1. 2.1 Custom DNA Oligos Industry Trends
  2. 2.2 Custom DNA Oligos Industry Drivers
  3. 2.3 Custom DNA Oligos Industry Opportunities and Challenges
  4. 2.4 Custom DNA Oligos Industry Restraints
3 Custom DNA Oligos Market by Company
  1. 3.1 Global Custom DNA Oligos Company Revenue Ranking in 2025
  2. 3.2 Global Custom DNA Oligos Revenue by Company (2021-2026)
  3. 3.3 Global Custom DNA Oligos Company Ranking (2024-2026)
  4. 3.4 Global Custom DNA Oligos Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom DNA Oligos Company Product Type and Application
  6. 3.6 Global Custom DNA Oligos Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom DNA Oligos Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom DNA Oligos Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom DNA Oligos Market by Type
  1. 4.1 Custom DNA Oligos Type Introduction
  2. 4.1.1 Common Primer Synthesis
  3. 4.1.2 Modified Primer Synthesis
  4. 4.2 Global Custom DNA Oligos Sales Value by Type
  5. 4.2.1 Global Custom DNA Oligos Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Custom DNA Oligos Sales Value by Type (2021-2032)
  7. 4.2.3 Global Custom DNA Oligos Sales Value Share by Type (2021-2032)
5 Custom DNA Oligos Market by Application
  1. 5.1 Custom DNA Oligos Application Introduction
  2. 5.1.1 Biotech Company
  3. 5.1.2 Academic Scientific Research Institution
  4. 5.2 Global Custom DNA Oligos Sales Value by Application
  5. 5.2.1 Global Custom DNA Oligos Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Custom DNA Oligos Sales Value by Application (2021-2032)
  7. 5.2.3 Global Custom DNA Oligos Sales Value Share by Application (2021-2032)
6 Custom DNA Oligos Regional Value Analysis
  1. 6.1 Global Custom DNA Oligos Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom DNA Oligos Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom DNA Oligos Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom DNA Oligos Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom DNA Oligos Sales Value (2021-2032)
  7. 6.3.2 North America Custom DNA Oligos Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom DNA Oligos Sales Value (2021-2032)
  10. 6.4.2 Europe Custom DNA Oligos Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom DNA Oligos Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom DNA Oligos Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom DNA Oligos Sales Value (2021-2032)
  16. 6.6.2 South America Custom DNA Oligos Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom DNA Oligos Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom DNA Oligos Sales Value Share by Country, 2025 VS 2032
7 Custom DNA Oligos Country-level Value Analysis
  1. 7.1 Global Custom DNA Oligos Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom DNA Oligos Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom DNA Oligos Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom DNA Oligos Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom DNA Oligos Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom DNA Oligos Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom DNA Oligos Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan GeneCreate Biological Engineering
  2. 8.1.1 Wuhan GeneCreate Biological Engineering Company Information
  3. 8.1.2 Wuhan GeneCreate Biological Engineering Business Overview
  4. 8.1.3 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Product Portfolio
  6. 8.1.5 Wuhan GeneCreate Biological Engineering Recent Developments
  7. 8.2 General Biol
  8. 8.2.1 General Biol Company Information
  9. 8.2.2 General Biol Business Overview
  10. 8.2.3 General Biol Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  11. 8.2.4 General Biol Custom DNA Oligos Product Portfolio
  12. 8.2.5 General Biol Recent Developments
  13. 8.3 Atantares
  14. 8.3.1 Atantares Company Information
  15. 8.3.2 Atantares Business Overview
  16. 8.3.3 Atantares Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Atantares Custom DNA Oligos Product Portfolio
  18. 8.3.5 Atantares Recent Developments
  19. 8.4 Beyotime
  20. 8.4.1 Beyotime Company Information
  21. 8.4.2 Beyotime Business Overview
  22. 8.4.3 Beyotime Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beyotime Custom DNA Oligos Product Portfolio
  24. 8.4.5 Beyotime Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Custom DNA Oligos Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Custom DNA Oligos Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Genscript
  38. 8.7.1 Genscript Company Information
  39. 8.7.2 Genscript Business Overview
  40. 8.7.3 Genscript Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genscript Custom DNA Oligos Product Portfolio
  42. 8.7.5 Genscript Recent Developments
  43. 8.8 Guangzhou RiboBio
  44. 8.8.1 Guangzhou RiboBio Company Information
  45. 8.8.2 Guangzhou RiboBio Business Overview
  46. 8.8.3 Guangzhou RiboBio Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou RiboBio Custom DNA Oligos Product Portfolio
  48. 8.8.5 Guangzhou RiboBio Recent Developments
  49. 8.9 Tsingke
  50. 8.9.1 Tsingke Company Information
  51. 8.9.2 Tsingke Business Overview
  52. 8.9.3 Tsingke Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tsingke Custom DNA Oligos Product Portfolio
  54. 8.9.5 Tsingke Recent Developments
  55. 8.10 Abace Biotechnology
  56. 8.10.1 Abace Biotechnology Company Information
  57. 8.10.2 Abace Biotechnology Business Overview
  58. 8.10.3 Abace Biotechnology Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abace Biotechnology Custom DNA Oligos Product Portfolio
  60. 8.10.5 Abace Biotechnology Recent Developments
  61. 8.11 TriLink BioTechnologies
  62. 8.11.1 TriLink BioTechnologies Company Information
  63. 8.11.2 TriLink BioTechnologies Business Overview
  64. 8.11.3 TriLink BioTechnologies Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TriLink BioTechnologies Custom DNA Oligos Product Portfolio
  66. 8.11.5 TriLink BioTechnologies Recent Developments
  67. 8.12 Synbio Technologies
  68. 8.12.1 Synbio Technologies Company Information
  69. 8.12.2 Synbio Technologies Business Overview
  70. 8.12.3 Synbio Technologies Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Synbio Technologies Custom DNA Oligos Product Portfolio
  72. 8.12.5 Synbio Technologies Recent Developments
  73. 8.13 Macrogen
  74. 8.13.1 Macrogen Company Information
  75. 8.13.2 Macrogen Business Overview
  76. 8.13.3 Macrogen Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Macrogen Custom DNA Oligos Product Portfolio
  78. 8.13.5 Macrogen Recent Developments
  79. 8.14 Integrated DNA Technologies (IDT)
  80. 8.14.1 Integrated DNA Technologies (IDT) Company Information
  81. 8.14.2 Integrated DNA Technologies (IDT) Business Overview
  82. 8.14.3 Integrated DNA Technologies (IDT) Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Integrated DNA Technologies (IDT) Custom DNA Oligos Product Portfolio
  84. 8.14.5 Integrated DNA Technologies (IDT) Recent Developments
  85. 8.15 Eurogentec
  86. 8.15.1 Eurogentec Company Information
  87. 8.15.2 Eurogentec Business Overview
  88. 8.15.3 Eurogentec Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eurogentec Custom DNA Oligos Product Portfolio
  90. 8.15.5 Eurogentec Recent Developments
  91. 8.16 Cusabio
  92. 8.16.1 Cusabio Company Information
  93. 8.16.2 Cusabio Business Overview
  94. 8.16.3 Cusabio Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cusabio Custom DNA Oligos Product Portfolio
  96. 8.16.5 Cusabio Recent Developments
  97. 8.17 BBI Life Sciences
  98. 8.17.1 BBI Life Sciences Company Information
  99. 8.17.2 BBI Life Sciences Business Overview
  100. 8.17.3 BBI Life Sciences Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BBI Life Sciences Custom DNA Oligos Product Portfolio
  102. 8.17.5 BBI Life Sciences Recent Developments
  103. 8.18 Azenta Life Sciences
  104. 8.18.1 Azenta Life Sciences Company Information
  105. 8.18.2 Azenta Life Sciences Business Overview
  106. 8.18.3 Azenta Life Sciences Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Azenta Life Sciences Custom DNA Oligos Product Portfolio
  108. 8.18.5 Azenta Life Sciences Recent Developments
  109. 8.19 Aurigene Pharmaceutical Services
  110. 8.19.1 Aurigene Pharmaceutical Services Company Information
  111. 8.19.2 Aurigene Pharmaceutical Services Business Overview
  112. 8.19.3 Aurigene Pharmaceutical Services Custom DNA Oligos Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aurigene Pharmaceutical Services Custom DNA Oligos Product Portfolio
  114. 8.19.5 Aurigene Pharmaceutical Services Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst